Patent details

Basic Information

Publication number:

EP0388232

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP903028660

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NANBV diagnostics and vaccines

French Title of Invention:

Diagnostics et vaccins de NANBV

German Title of Invention:

NANBV-Diagnostika und Vakzine

SPC Number:

Dates

Filing date:

16/03/1990

Grant date:

12/01/2005

EP Publication Date:

12/01/2005

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/09/1990

EP B1 Publication Date:

12/01/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

16/03/2010

Renunciation date:

Revocation date:

16/03/2010

Annulment date:

Owner

From:

28/12/2006

 

 

Name:

Novartis Vaccines and Diagnostics, Inc.

Address:

4560 Horton Street, Emeryville, CA 94608, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

12/01/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Houghton Michael

Address:

United States (US)

2

Name:

Choo Qui-Lim

Address:

United States (US)

3

Name:

Kuo George

Address:

United States (US)

Priority

1

Priority Number:

325338

Priority Date:

17/03/1989

Priority Country:

United States (US)

2

Priority Number:

341334

Priority Date:

20/04/1989

Priority Country:

United States (US)

3

Priority Number:

355002

Priority Date:

18/05/1989

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/51;

Filing date	Document type	Number of pages